novartis glp-1 receptor agonist The Impact of Agonists on Ocular Disease Adverse Effects of GLP-1 Receptor
Description
Two of the few recently recognized small molecules that succeeded in entering clinical development, namely LY3502790 and PF-06882961, activate the canonical G protein signaling activity only in the GLP-1 receptor with Trp33 ECD [38,42]
[DOI] [PubMed] [Google Scholar] 173
PMID: 36117625
10.1016/j.ijcha.2023.101218 77
We performed metarregression to evaluate if there was a trend towards higher incidence of pancreatic cancer in studies with longer duration, however no association between duration and the outcome was observed
How are GLP-1 medications currently given in the UK
